menu_open Columnists
Joel Lexchin

Joel Lexchin

The Star

We use cookies to provide some features and experiences in QOSHE

More information  .  Close

How Donald Trump’s tariffs threaten Canadians’ access to prescription drugs

U.S. tariffs present not only a risk of Canadian job losses — and loss of access to employer-sponsored drug plans — but also the risk of higher...

04.05.2025 10

The Conversation

Joel Lexchin

Pharma company funding for patient advocacy groups needs to be transparent

Patient groups should be playing a central role in Canada’s health-care system, advocating for their members by promoting the visibility of their...

03.10.2024 4

The Conversation

Joel Lexchin